Header Logo

Kimberly Lenz

Concepts (83)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medicaid
10
2019
367
0.650
 Why?
Analgesics, Opioid
4
2019
524
0.560
 Why?
Pain
3
2019
398
0.550
 Why?
Medication Therapy Management
3
2018
18
0.370
 Why?
Antiviral Agents
3
2018
323
0.320
 Why?
Practice Patterns, Physicians'
5
2019
706
0.300
 Why?
Hepatitis C
2
2016
145
0.220
 Why?
United States
10
2019
8041
0.160
 Why?
Drug Utilization Review
2
2017
50
0.160
 Why?
Chloride Channel Agonists
1
2019
2
0.150
 Why?
Aminophenols
1
2019
3
0.150
 Why?
Drug and Narcotic Control
2
2017
27
0.150
 Why?
Benzodioxoles
1
2019
12
0.150
 Why?
Aminopyridines
1
2019
33
0.150
 Why?
Quinolones
1
2019
25
0.150
 Why?
Uridine Monophosphate
1
2018
8
0.140
 Why?
Fluorenes
1
2018
13
0.140
 Why?
Cystic Fibrosis
1
2019
127
0.140
 Why?
Benzimidazoles
1
2018
56
0.140
 Why?
Psychotropic Drugs
1
2018
81
0.130
 Why?
Insurance, Pharmaceutical Services
2
2014
17
0.130
 Why?
Hydrocodone
1
2017
6
0.130
 Why?
Hepatitis C, Chronic
1
2018
89
0.130
 Why?
Drug Prescriptions
1
2018
164
0.130
 Why?
Hepacivirus
1
2018
134
0.130
 Why?
Progesterone
1
2017
165
0.130
 Why?
Opioid-Related Disorders
2
2014
522
0.120
 Why?
Medication Adherence
1
2017
198
0.120
 Why?
Premature Birth
1
2017
114
0.120
 Why?
Prescription Drug Diversion
1
2014
6
0.110
 Why?
Lung
1
2019
965
0.110
 Why?
Prescription Drug Misuse
1
2014
20
0.100
 Why?
State Government
1
2014
32
0.100
 Why?
Drug Combinations
3
2019
166
0.100
 Why?
Drug Interactions
1
2014
124
0.100
 Why?
Managed Care Programs
1
2014
86
0.100
 Why?
Retrospective Studies
7
2018
6803
0.090
 Why?
Health Services Accessibility
1
2016
581
0.080
 Why?
Mental Disorders
1
2018
811
0.080
 Why?
Treatment Outcome
3
2016
5758
0.080
 Why?
Young Adult
4
2019
4771
0.070
 Why?
Adolescent
4
2019
6291
0.070
 Why?
Adult
6
2019
17230
0.060
 Why?
Humans
10
2019
64729
0.060
 Why?
Drug Costs
2
2016
55
0.060
 Why?
Cost Savings
2
2016
57
0.060
 Why?
Cost-Benefit Analysis
2
2017
315
0.050
 Why?
Female
7
2019
33739
0.050
 Why?
Program Evaluation
2
2018
489
0.050
 Why?
Middle Aged
5
2019
18106
0.050
 Why?
Pharmacists
2
2016
130
0.050
 Why?
Male
6
2019
30790
0.050
 Why?
Massachusetts
2
2018
2137
0.040
 Why?
Cohort Studies
2
2017
2603
0.040
 Why?
Child
2
2019
4599
0.040
 Why?
Cystic Fibrosis Transmembrane Conductance Regulator
1
2019
81
0.040
 Why?
Sustained Virologic Response
1
2018
9
0.040
 Why?
Sofosbuvir
1
2018
16
0.040
 Why?
Ribavirin
1
2018
22
0.040
 Why?
Polypharmacy
1
2018
65
0.030
 Why?
Hydroxyprogesterones
1
2017
5
0.030
 Why?
Treatment Failure
1
2018
206
0.030
 Why?
Controlled Substances
1
2017
4
0.030
 Why?
Viral Load
1
2018
228
0.030
 Why?
RNA, Viral
1
2018
265
0.030
 Why?
Drug Therapy, Combination
1
2018
461
0.030
 Why?
Dose-Response Relationship, Drug
1
2019
851
0.030
 Why?
Gestational Age
1
2017
195
0.030
 Why?
Psychiatry
1
2018
128
0.030
 Why?
Genotype
1
2018
670
0.030
 Why?
Evidence-Based Medicine
1
2018
456
0.030
 Why?
Insurance Claim Review
1
2016
75
0.030
 Why?
Pregnancy Outcome
1
2017
197
0.030
 Why?
Drug Monitoring
1
2016
202
0.030
 Why?
Government Regulation
1
2014
39
0.030
 Why?
Interdisciplinary Communication
1
2014
105
0.030
 Why?
Physician's Role
1
2014
122
0.020
 Why?
Cooperative Behavior
1
2014
229
0.020
 Why?
Health Policy
1
2014
192
0.020
 Why?
Mutation
1
2019
2658
0.020
 Why?
Pregnancy
1
2017
2363
0.020
 Why?
Time Factors
1
2014
3745
0.020
 Why?
Aged
1
2018
14834
0.010
 Why?
Lenz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (83)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_